TKThomas Karvunidis

Thomas Karvunidis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas Karvunidis has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Year 2023 in review - Sepsis

    by T Karvunidis

    Leto?n? souhrn kriticky diskutuje v?znamn? publikace v oblastech adjuvantn? kortikoterapie u komunitn? pneumonie, kontroly glykemie a supraventrikul?rn?ch arytmi?, a problematiku tekutinov? l??by u kriticky nemocn?ch v sepsi. Leto?n? souhrn kriticky diskutuje v?znamn? publikace v oblastech adjuvantn? kortikoterapie u komunitn? pneumonie, kontroly glykemie a supraventrikul?rn?ch arytmi?, a problematiku tekutinov? l??by u kriticky nemocn?ch v sepsi.


  • Open Access

    Critical care for multimorbid patients

    by Marcela Královcová, Thomas Karvunidis, Martin Matějovič

    Multimorbidita - sou?asn? p??tomnost v?ce chronick?ch onemocn?n? - je u kriticky nemocn?ch velmi ?ast?. Jej? prevalence je zhruba 40-85 % a trendov? se d?le zvy?uje. Ur?it? chronick? onemocn?n?, jako nap?. diabetes mellitus, obezita, chronick?... Multimorbidita - sou?asn? p??tomnost v?ce chronick?ch onemocn?n? - je u kriticky nemocn?ch velmi ?ast?. Jej? prevalence je zhruba 40-85 % a trendov? se d?le zvy?uje. Ur?it? chronick? onemocn?n?, jako nap?. diabetes mellitus, obezita, chronick?...

  • Open Access

    Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19

    by Ya Wang, Klaus Schughart, Tiana Maria Pelaia, Tracy Chew, Karan Kim, Thomas Karvunidis, Ben Knippenberg, Sally Teoh, Amy L. Phu, Kirsty R. Short, et al.

    Patients with preexisting metabolic disorders such as diabetes are at a higher risk of developing severe coronavirus disease 2019 (COVID-19). Mitochondrion, the very organelle that controls cellular metabolism, holds the key to understanding disease progression at the cellular level. Our current study aimed to understand how cellular metabolism contributes to COVID-19 outcomes. Metacore pathway enrichment analyses on differentially expressed genes (encoded by both mitochondrial and nuclear deoxyribonucleic acid (DNA)) involved in cellular metabolism, regulation of mitochondrial respiration and organization, and apoptosis, was performed on RNA sequencing (RNASeq) data from blood samples collected from healthy controls and patients with mild/moderate or severe COVID-19. Genes from the enriched pathways were analyzed by network analysis to uncover interactions among them and up- or downstream genes within each pathway. Compared to the mild/moderate COVID-19, the upregulation of a myriad of growth factor and cell cycle signaling pathways, with concomitant downregulation of interferon signaling pathways, were observed in the severe group. Matrix metallopeptidase 9 (MMP9) was found in five of the top 10 upregulated pathways, indicating its potential as therapeutic target against COVID-19. In summary, our data demonstrates aberrant activation of endocrine signaling in severe COVID-19, and its implication in immune and metabolic dysfunction.


  • Open Access

    Year 2022 in review - Sepsis

    by T Karvunidis, M Matějovič

    Leto?n? souhrn diskutuje v?znamn? publikace v oblastech antibiotick? l??by, tekutinov? terapie, metabolick? resuscitace, mimot?ln?ch hemoadsorp?n?ch metod, kontroly teploty a shrnuje nov? pokroky v subfenotypizaci kriticky nemocn?ch v sepsi. Leto?n? souhrn diskutuje v?znamn? publikace v oblastech antibiotick? l??by, tekutinov? terapie, metabolick? resuscitace, mimot?ln?ch hemoadsorp?n?ch metod, kontroly teploty a shrnuje nov? pokroky v subfenotypizaci kriticky nemocn?ch v sepsi.


  • Open Access

    Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs

    by Jiri Chvojka, Roman Sykora, Ales Krouzecky, Jaroslav Radej, Veronika Varnerova, Thomas Karvunidis, Ondrej Hes, Ivan Novak, Peter Radermacher, Martin Matejovic

    Introduction: Our understanding of septic acute kidney injury (AKI) remains incomplete. A fundamental step is the use of animal models designed to meet the criteria of human sepsis. Therefore, we dynamically assessed renal haemodynamic, microvascular and metabolic responses to, and ultrastructural sequelae of, sepsis in a porcine model of faecal peritonitis-induced progressive hyperdynamic sepsis. Methods: In eight anaesthetised and mechanically ventilated pigs, faecal peritonitis was induced by inoculating autologous faeces. Six sham-operated animals served as time-matched controls. Noradrenaline was administered to maintain mean arterial pressure (MAP) greater than or equal to 65 mmHg. Before and at 12, 18 and 22 hours of peritonitis systemic haemodynamics, total renal (ultrasound Doppler) and cortex microvascular (laser Doppler) blood flow, oxygen transport and renal venous pressure, acid base balance and lactate/pyruvate ratios were measured. Postmortem histological analysis of kidney tissue was performed. Results: All septic pigs developed hyperdynamic shock with AKI as evidenced by a 30% increase in plasma creatinine levels. Kidney blood flow remained well-preserved and renal vascular resistance did not change either. Renal perfusion pressure significantly decreased in the AKI group as a result of gradually increased renal venous pressure. In parallel with a significant decrease in renal cortex microvascular perfusion, progressive renal venous acidosis and an increase in lactate/pyruvate ratio developed, while renal oxygen consumption remained unchanged. Renal histology revealed only subtle changes without signs of acute tubular necrosis. Conclusion: The results of this experimental study argue against the concept of renal vasoconstriction and tubular necrosis as physiological and morphological substrates of early septic AKI. Renal venous congestion might be a hidden and clinically unrecognised contributor to the development of kidney dysfunction.


  • Identification of a novel HLA‐DRB1*14 allele, HLA‐DRB1*1458, by sequence‐based typing

    by T. Karvunidis, P. Jindra, G. Fischer, P. Venigova, A. Dorner, V. Koza

    Identification of a novel HLA‐DRB1*1458 allele within a Caucasian individual using sequence‐based typing.